Today: 1 July 2026
Costco stock price drifts lower as tariff refund fight looms — what COST investors watch next
22 February 2026
1 min read

Costco stock price drifts lower as tariff refund fight looms — what COST investors watch next

New York, February 22, 2026, 14:35 ET — Market closed.

  • Costco Wholesale ended the session at $985.27, slipping 0.26%.
  • After the Supreme Court’s decision threw U.S. tariff policy into uncertainty, Treasury Secretary Scott Bessent warned it might be years before any refunds are processed.

Costco Wholesale Corporation closed out Friday at $985.27, a slip of 0.26%, keeping the stock roughly 7.7% under its 52-week peak, per the company’s investor relations page.

Stocks on Wall Street edged higher after the U.S. Supreme Court overturned President Donald Trump’s broad tariffs, nudging investors toward riskier assets. The S&P 500 added 0.69%, while the Nasdaq climbed 0.90%, according to Reuters.

Why does it matter right now? The tariff decision puts the focus squarely on who actually pockets any refunds—and how soon. Court filings reveal more than 1,800 importers, Costco among them, have gone to court for tariff paybacks since Feb. 1, 2025. “A lot of goodwill” will be needed to fend off a flood of fights, Andrew Wilson, deputy secretary general at the International Chamber of Commerce, warned. Reuters

Refunds won’t come automatically. The Supreme Court left the repayment process undefined, so importers could be forced to seek relief in the U.S. Court of International Trade. Justice Brett Kavanaugh, in dissent, called the prospect of getting money back “a mess,” according to Reuters. Reuters

The weekend brought another change. Trump fired back at the ruling, slapping a fresh tariff on all imports and bumping that up to 15%—the legal ceiling—less than a day later, according to Reuters.

Costco edged down Friday, diverging from other retail names. Walmart dropped 1.5%. Target managed a 0.9% gain. The SPDR S&P 500 ETF advanced roughly 0.7%.

Market strategists called the ruling both a relief and a head-scratcher. Eric Merlis, co-head of global markets at Citizens, pointed out the court “stopped short of clarifying eligibility for tariff refunds, leaving a key source of uncertainty intact.” Reuters

Costco’s next move comes into focus with its fiscal Q2 earnings call set for March 5. Investors can also mark April 8 for the company’s March sales update, as noted on its investor relations page.

It’s a tricky situation: investors remain in the dark on both the speed of any tariff refunds and just how much extra cost actually lingers in the supply chain. U.S. markets come back online Monday, and headlines about tariffs could grab the spotlight right out of the gate. For COST, eyes are on the March 5 earnings report and call as the next major event.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Adient, ArcBest, GEO Group Land on Zacks Strong Sell List
    July 1, 2026, 5:24 AM EDT. Zacks Investment Research put Adient plc (ADNT), ArcBest Corporation (ARCB), and The GEO Group (GEO) on its Rank #5 (Strong Sell) list as of July 1. Adient, which supplies car seats, had its earnings estimate for this year lowered 10.7% over the last 60 days. ArcBest, in freight and logistics, saw its earnings projection drop 15%. GEO, which operates secure facilities, was cut by 3.8%. Zacks also pointed out a top pick with potential to double, backed by strong demand and share buybacks. Updated rankings are meant to help investors follow shifting earnings outlooks during volatile trading.
Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Previous Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop